Atsena Therapeutics vs GenSight Biologics
Atsena Therapeutics
Clinical-stage gene therapy company developing treatments to reverse/prevent blindness from inherited retinal diseases
46 employees · est. 2019
GenSight Biologics
Applying pathbreaking science to transform the lives of patients with severe retinal neurodegenerative diseases
34 employees · est. 2013 · Paris, France
GenSight Biologics is the older company (2019 vs 2013).
Side-by-Side Comparison
| Metric | Atsena Therapeutics | GenSight Biologics |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2013 older |
| Headquarters | ||
| Headquarters | Not tracked yet | Paris, France |
| Employees | ||
| Employees | 46 | 34 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series C | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $237.62M | $245.64M |
| Funding Rounds | ||
| Funding Rounds | 5 | 17 |
| Taxonomy | ||
| Taxonomy | Clinical-stage CompanyOcular Gene TherapyInherited BlindnessATSN-201ATSN-101LCA1 +9 | Clinical-stage BiotechGene TherapyRetinal DiseasesNeurodegenerative DiseasesMitochondrial Targeting SequenceOptogenetics +8 |
| Website | ||
| Website | atsenatx.com | gensight-biologics.com |
About Atsena Therapeutics
Atsena Therapeutics is a biotechnology startup focusing on clinical-stage ocular gene therapy for treating inherited forms of blindness. The company's flagship programs include ATSN-201 for X-linked retinoschisis (XLRS) and ATSN-101 for GUCY2D-associated Leber congenital amaurosis (LCA1). Notably, t...
About GenSight Biologics
GenSight Biologics is a biotechnology startup focused on developing groundbreaking therapies for severe retinal neurodegenerative diseases. Leveraging the Mitochondrial Targeting Sequence (MTS) and optogenetics, the company is striving to preserve or restore vision in patients with degenerative reti...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches Atsena Therapeutics and GenSight Biologics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when Atsena Therapeutics or GenSight Biologics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare Atsena Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Atsena Therapeutics on 9 Jun 2026, and GenSight Biologics on 11 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
